Drugs / Carbon-11 Sodium Acetate
Carbon-11 Sodium Acetate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01961934 | May 2014 → May 2016 | glioma | Phoenix Molecular Imaging | Withdrawn | No outcome recorded Stop: Business |
| Phase not stated1 trial | ||||||
| — | NCT02826395 | — | prostate cancer | Jonsson Comprehensive Cancer Center | No longer available | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbon-11 Sodium Acetate | “Carbon-11-Sodium Acetate Positron Emission Tomography/Computed Tomography (PET/CT) Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression” NCT01961934 ↗ |
| Modality | Diagnostic / imaging agent | “Carbon Acetate PET/CT imaging” NCT01961934 ↗ |
| Route | Intravenous | “Participant will be injected with 20 - 40mCi of 11C-Sodium Acetate intravenously (i.v.).” NCT02826395 ↗ |